Health Care: Drugs

Targacept Inc (TRGT: NASDAQ)

$2.8 n/a | n/a%
08/19/14 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 2.80
52 Week High 6.11
52 Week Low 2.68
Avg. Daily Vol. (Mil) 0.33
Beta (3 year) 2.09
Share Related Items
Mkt Cap (Mil) 94.62
Shares Out (Mil) 33.79
Float (Mil) 22.99
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 13.00
Current Ratio 13.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.01
Valuation Ratios
Price Earnings n.a.
Price/Sales 438.07
Price/Book 0.81
Price/Cash Flow -2.00
Per Share Data
Earnings -1.47
Sales 0.01
Book Value 3.46
Cash Flow -1.43
Business Summary
Targacept, Inc., is a biopharmaceutical company, which is engaged in the design, discovery and development of NNR Therapeutics, a new class of drugs for the treatment of diseases and disorders of the central nervous system.
General Information
100 North Main Street
Suite 1510
Winston-Salem, NC 27101
www.targacept.com
Industry : Drugs
Sector: Health Care
Employees: 39
CEO: Stephen A. Hill,B.M.
Short Interest
Current Month (Mil) 1.25
Previous Month (Mil) 1.17
Short Interest Ratio (Days) 3.30
Management Effectiveness
Return on Equity n.a.
Return on Assets -39.70
Return on Investments -42.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with TRGT

Latest TRGT Headlines from TheStreet

More Financial News for TRGT

Press Releases for TRGT

See All Press Releases

Partner Headlines for TRGT

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter